Aclaris Therapeutics
ACRS
ACRS
133 hedge funds and large institutions have $737M invested in Aclaris Therapeutics in 2023 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 53 increasing their positions, 40 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
10% less funds holding
Funds holding: 148 → 133 (-15)
21% less call options, than puts
Call options by funds: $13M | Put options by funds: $16.5M
56% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 27
Holders
133
Holding in Top 10
5
Calls
$13M
Puts
$16.5M
Top Buyers
| 1 | +$9.94M | |
| 2 | +$7.95M | |
| 3 | +$7.78M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
+$5.44M |
| 5 |
BlackRock
New York
|
+$4.97M |
Top Sellers
| 1 | -$13.8M | |
| 2 | -$5.55M | |
| 3 | -$5.14M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$5.13M |
| 5 |
OCA
Octagon Capital Advisors
New York
|
-$4.67M |